Current status of anaplastic thyroid carcinoma  

作　　者：Abrahams Ocanto Lisselott Torres Felipe Couñago 

机构地区：[1]Department of Radiation Oncology,San Francisco de Asís University Hospital,Genesis Care,Madrid 28002,Spain [2]Department of Radiation Oncology,Vithas La Milagrosa University Hospital,Genesis Care,Madrid 28010,Spain

出　　处：《World Journal of Clinical Oncology》2024年第6期684-686,共3页世界临床肿瘤学杂志（英文版）

摘　　要：In this editorial we comment on the article by Pavlidis et al,published in the recent issue of the World Journal of Oncology.We focus on the recent contributions in the management of anaplastic thyroid carcinoma,highlighting the importance of surgery and radiotherapy as first line therapies in its management and the introduction of new systemic therapies beyond chemotherapy,focused on molecular alterations,an essential step in the diagnosis and included in clinical guidelines for the selection of the ideal treatment.In contrast to other neoplasms,immunotherapy,is still beginning in studies of this pathology with encouraging results.Therefore,multimodal management of the pathology together with new drugs seems to be the logical step to increase the survival of this neoplasm.

关 键 词：Anaplastic carcinoma Thyroid diseases SURGERY RADIOTHERAPY Immunoth-erapy 

分 类 号：R736.1[医药卫生—肿瘤]